日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney disease.

脯氨酰羟化酶抑制剂地西达司他通过增强慢性肾病小鼠的胞吞作用来改善中风预后

Kaur Harpreet, Pandey Nilesh, Chandaluri Lakshmi, Shaaban Nirvana, Martinez Alexa, Kidder Evan, Patel Vishal J, Kshirsagar Samadhan G, Kumar Dhananjay, Frausto Louise, Pandit Rajan, Richard Koral S E, Anand Sumit Kumar, Das Sandeep, Vikram Ajit, Magdy Tarek, Lu Xiao-Hong, Orr A Wayne, Patel Harilal, Trivedi Ravi Kumar, Kansagra Kevinkumar, Joharapurkar Amit A, Parmar Deven V, Jain Mukul R, Rom Oren, Yurdagul Arif Jr, Dhanesha Nirav

Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state

脯氨酰羟化酶抑制剂 desidustat 改善红细胞生成素低反应状态下的贫血

Amit A Joharapurkar, Vishal J Patel, Samadhan G Kshirsagar, Maulik S Patel, Hardikkumar H Savsani, Chetan Kajavadara, Darshan Valani, Mukul R Jain

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus

胰高血糖素样肽-1 和胰高血糖素受体的共激动剂可改善肥胖和糖尿病小鼠模型中的肾脏损伤

Vishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, Brijesh K Sutariya, Maulik S Patel, Hiren M Patel, Dheerendra K Pandey, Rajesh H Bahekar, Mukul R Jain

ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus

ZY15557 是一种新型的长效二肽基肽酶-4抑制剂,用于治疗2型糖尿病。

Jain, Mukul R; Joharapurkar, Amit A; Kshirsagar, Samadhan G; Patel, Vishal J; Bahekar, Rajesh H; Patel, Harilal V; Jadav, Pradip A; Patel, Pankaj R; Desai, Ranjit C